Headquarters: New York, NY
Investor Relations: Zach Herschfus / +1-844-9-ORAMED / zach@oramed.com
Description
Oramed Pharmaceuticals is a platform technology pioneer in the field of oral delivery solutions for drugs currently delivered via injection. Established in 2006, with offices in the United States and Israel, Oramed has developed a novel Protein Oral Delivery technology. Oramed is seeking to transform the treatment of diabetes through its proprietary lead candidate, ORMD-0801.
Industry
Life Sciences
Year Founded
Ownership
Public
Exchange / Symbol
NASDAQ: ORMP
Public Since
Chief Executive Officer
Chairman of the Board
Chief Financial Officer
Insider Ownership
Key Investors
Employee Count
Auditors
Investment Bankers
Law Firms
In the CEOs Own Words
Corporate Mission
Proudest Accomplishment
Next Milestone
Geographic Markets Served
Growth Drivers
Growth Headwinds
Indicia of Customer Satisfaction
Scalability
Workforce
Focus of Recruitment
Research and Development
Patent Count
Economic Sensitivity
Unique Metrics
Greatest Concern
Company Reports and Communications
SEC Filings
" target="_blank">